The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Elevated Chlamydia pneumoniae Antibodies, Cardiovascular Events, and Azithromycin in Male Survivors of Myocardial Infarction
Abstract
Background The clinical significance of the association between elevated anti– Chlamydia pneumoniae (Cp) antibody titres and coronary heart disease (CHD) is unclear. We explored the relationship between antibodies against Cp and future cardiovascular events in male survivors of myocardial infarction (MI). The effect of azithromycin antibiotic therapy was assessed in a subgroup of post-MI patients. Methods and Results We screened 220 consecutive male survivors of MI for anti-Cp antibodies. Of these, 213 patients were stratified into three groups: group Cp-ve (n=59), no detectable Cp antibodies; group Cp-I (n=74), intermediate titres of 1/8 to 1/32 dilution; and group Cp+ve (n=80), seropositive at ≥1/64 dilution. Patients with persisting seropositivity of ≥1/64 were randomized to either oral azithromycin (Cp+ve-A, 500 mg/d for 3 days [n=28] or 500 mg/d for 6 days [n=12]) or placebo (Cp+ve-P, n=20). Cp+ve-NR (n=20) represented patients not recruited into the antibiotic trial. The incidence of adverse cardiovascular events (over a mean follow-up period of 18±4 months) was recorded and shown to increase with increasing anti-Cp titre: Cp-ve, n=4 (7%); Cp-I, n=11 (15%); Cp+ve-NR, n=6 (30%); and Cp+ve-P, n=5 (25%). Cp+ve-NR and Cp+ve-P groups had a fourfold-increased risk for adverse cardiovascular events compared with the Cp-ve group (odds ratio [OR], 4.2; 95% confidence interval [CI], 1.2 to 15.5; P =.03). In contrast, the OR for cardiovascular events in patients receiving azithromycin (Cp+ve-A, single or double course) was the same as in the Cp-ve group (OR, 0.9; 95% CI, 0.2 to 4.6, P =NS). Patients receiving azithromycin were more likely to experience a decrease in IgG anti-Cp titres than were those in the placebo group ( P =.02). Conclusions An increased anti-Cp antibody titre may be a predictor for further adverse cardiovascular events in post-MI patients. Taking a short course of azithromycin may lower this risk, possibly by acting against Cp.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Saikku, P., Mattila, K., Nieminen, M. S., Huttunen, J. K., Leinonen, M., Ekman, M.-R., Mäkelä, P. H., & Valtonen, V (1988) · The Lancet · doi:10.1016/s0140-6736(88)90741-6 · Cited by 1,964
Saikku, P., Leinonen, M., Tenkanen, L., Linnanmäki, E., Ekman, M.-R., Manninen, V., Mänttäri, M., Frick, M. H., & Huttunen, J. K. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-4-273 · Cited by 786
Demonstration of Chlamydia pneumoniae in Atherosclerotic Lesions of Coronary Arteries
Kuo, C.-C., Shor, A., Campbell, L. A., Fukushi, H., Patton, D. L., & Grayston, J. T. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.4.841 · Cited by 762
The pharmacokinetics of azithromycin in human serum and tissues
Foulds, G., Shepard, R. M., & Johnson, R. B. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.suppl_a.73 · Cited by 755
Patel, P., Mendall, M. A., Carrington, D., Strachan, D. P., Leatham, E., Molineaux, N., Levy, J., Blakeston, C., Seymour, C. A., Camm, A. J., et al. (1995) · BMJ · doi:10.1136/bmj.311.7007.711 · Cited by 592
Self-citationAssociation of serum antibodies to heat-shock protein 65 with carotid atherosclerosis
Xu, Q., Wick, G., Willeit, J., Marosi, M., Kiechl, S., Luef, G., Kleindienst, R., Stulnig, T., Wick, G., & Oberhollenzer, F. (1993) · The Lancet · doi:10.1016/0140-6736(93)92613-x · Cited by 514
Muhlestein, J. B., Hammond, E. H., Carlquist, J. F., Radicke, E., Thomson, M. J., Karagounis, L. A., Woods, M. L., & Anderson, J. L. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00055-1 · Cited by 420
Thom, D. H. (1992) · JAMA · doi:10.1001/jama.268.1.68 · Cited by 397
Detection of Chlamydia pneumoniae TWAR in Human Coronary Atherectomy Tissues
Campbell, L. A., O'Brien, E. R., Cappuccio, A. L., Kuo, C.-C., Wang, S.-P., Stewart, D., Patton, D. L., Cummings, P. K., & Grayston, J. T. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.2.585 · Cited by 346
Cited by
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., et al. (2006) · Stroke · doi:10.1161/01.str.0000223048.70103.f1 · Cited by 1,368
Wood, D., De Backer, G., Faergeman, O., Graham, I., Mancia, G., & Pyörälä, K. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)90209-x · Cited by 1,255
Identification of Periodontal Pathogens in Atheromatous Plaques
Haraszthy, V. I., Zambon, J. J., Trevisan, M., Zeid, M., & Genco, R. J. (2000) · Journal of Periodontology · doi:10.1902/jop.2000.71.10.1554 · Cited by 1,120
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 905
Trends in hypertension epidemiology in India
Gupta, R. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001633 · Cited by 687
Biasucci, L. M., Liuzzo, G., Grillo, R. L., Caligiuri, G., Rebuzzi, A. G., Buffon, A., Summaria, F., Ginnetti, F., Fadda, G., & Maseri, A. (1999) · Circulation · doi:10.1161/01.cir.99.7.855 · Cited by 582
Libby, P., Egan, D., & Skarlatos, S. (1997) · Circulation · doi:10.1161/01.cir.96.11.4095 · Cited by 556
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes.
Liuzzo, G., Goronzy, J. J., Yang, H., Kopecky, S. L., Holmes, D. R., Frye, R. L., & Weyand, C. M. (2000) · Circulation · doi:10.1161/01.cir.101.25.2883 · Cited by 552
Kol, A., Sukhova, G. K., Lichtman, A. H., & Libby, P. (1998) · Circulation · doi:10.1161/01.cir.98.4.300 · Cited by 538
Hak, A. E., Stehouwer, C. D. A., Bots, M. L., Polderman, K. H., Schalkwijk, C. G., Westendorp, I. C. D., Hofman, A., & Witteman, J. C. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.8.1986 · Cited by 525
Inflammation and Infections as Risk Factors for Ischemic Stroke
Lindsberg, P. J., & Grau, A. J. (2003) · Stroke · doi:10.1161/01.str.0000089015.51603.cc · Cited by 519
Kol, A., Bourcier, T., Lichtman, A. H., & Libby, P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5310 · Cited by 510
Association of endotoxemia with carotid atherosclerosis and cardiovascular disease
Wiedermann, C. J., Kiechl, S., Dunzendorfer, S., Schratzberger, P., Egger, G., Oberhollenzer, F., & Willeit, J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00448-9 · Cited by 505
The interaction of bacterial pathogens with platelets
Fitzgerald, J. R., Foster, T. J., & Cox, D. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1425 · Cited by 489
Biasucci, L. M., Liuzzo, G., Fantuzzi, G., Caligiuri, G., Rebuzzi, A. G., Ginnetti, F., Dinarello, C. A., & Maseri, A. (1999) · Circulation · doi:10.1161/01.cir.99.16.2079 · Cited by 485
Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins
Abuja, P. M., & Albertini, R. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00393-x · Cited by 452
Chlamydia Infections and Heart Disease Linked Through Antigenic Mimicry
Bachmaier, K., Neu, N., de la Maza, L. M., Pal, S., Hessel, A., & Penninger, J. M. (1999) · Science · doi:10.1126/science.283.5406.1335 · Cited by 419
Ott, S. J., El Mokhtari, N. E., Musfeldt, M., Hellmig, S., Freitag, S., Rehman, A., Kühbacher, T., Nikolaus, S., Namsolleck, P., Blaut, M., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.579979 · Cited by 391
Acute respiratory-tract infections and risk of first-time acute myocardial infarction
Meier, C. R., Jick, S. S., Derby, L. E., Vasilakis, C., Jick, H., Meier, C., Jick, S., Derby, L., Vasilakis, C., & Jick, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11084-4 · Cited by 389
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.163 · Cited by 373
Gender differences in cardiovascular disease
Gao, Z., Chen, Z., Sun, A., & Deng, X. (2019) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2019.100025 · Cited by 373
Maass, M., Bartels, C., Engel, P. M., Mamat, U., & Sievers, H.-H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00016-3 · Cited by 367
Acute Coronary Syndromes: Unstable Angina and Non–Q-Wave Myocardial Infarction
Théroux, P., & Fuster, V. (1998) · Circulation · doi:10.1161/01.cir.97.12.1195 · Cited by 356
Severino, P., D'Amato, A., Pucci, M., Infusino, F., Adamo, F., Birtolo, L. I., Netti, L., Montefusco, G., Chimenti, C., Lavalle, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218118 · Cited by 349
Anderson, J. L., Muhlestein, J. B., Carlquist, J., Allen, A., Trehan, S., Nielson, C., Hall, S., Brady, J., Egger, M., Horne, B., et al. (1999) · Circulation · doi:10.1161/01.cir.99.12.1540 · Cited by 335
O'Connor, C. M., Dunne, M. W., Pfeffer, M. A., Muhlestein, J. B., Yao, L., Gupta, S., Benner, R. J., Fisher, M. R., Cook, T. D., & for the Investigators in the WIZARD Study (2003) · JAMA · doi:10.1001/jama.290.11.1459 · Cited by 328
Self-citationMehta, J. L., Saldeen, T. G. P., & Rand, K. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00093-x · Cited by 323
Role of Infection as a Risk Factor for Atherosclerosis, Myocardial Infarction, and Stroke
Mattila, K. J., Valtonen, V. V., Nieminen, M. S., & Asikainen, S. (1998) · Clinical Infectious Diseases · doi:10.1086/514570 · Cited by 309
Gurfinkel, E. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1283 · Cited by 304
Mayr, M., Kiechl, S., Willeit, J., Wick, G., & Xu, Q. (2000) · Circulation · doi:10.1161/01.cir.102.8.833 · Cited by 297
Antibiotic Treatment of Chlamydia pneumoniae after Acute Coronary Syndrome
Cannon, C. P., Braunwald, E., McCabe, C. H., Grayston, J. T., Muhlestein, B., Giugliano, R. P., Cairns, R., & Skene, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043528 · Cited by 291
<EMPH TYPE="ITAL">Chlamydia pneumoniae</EMPH> as an Emerging Risk Factor in Cardiovascular Disease
Kalayoglu, M. V. (2002) · JAMA · doi:10.1001/jama.288.21.2724 · Cited by 283
Background and Current Knowledge of Chlamydia pneumoniae and Atherosclerosis
Grayston, J. T. (2000) · The Journal of Infectious Diseases · doi:10.1086/315596 · Cited by 281
The role of plaque rupture and thrombosis in coronary artery disease
Zaman, A. G., Helft, G., Worthley, S. G., & Badimon, J. J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00479-7 · Cited by 280
Induction of Macrophage Foam Cell Formation by Chlamydia pneumoniae
Kalayoglu, M. V., & Byrne, G. I. (1998) · The Journal of Infectious Diseases · doi:10.1086/514241 · Cited by 275
Effects of Serine/Threonine Protein Phosphatases on Ion Channels in Excitable Membranes
Herzig, S., & Neumann, J. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.1.173 · Cited by 272
Association of virulent Helicobacter pylori strains with ischemic heart disease
(1999) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1016/s1053-0770(99)90189-1 · Cited by 268
Andraws, R., Berger, J. S., & Brown, D. L. (2005) · JAMA · doi:10.1001/jama.293.21.2641 · Cited by 235
Macrolide Antibiotics and the Risk of Cardiac Arrhythmias
Albert, R. K., & Schuller, J. L. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0385ci · Cited by 163
Periodontal therapy and cardiovascular risk
Orlandi, M., Graziani, F., & D'Aiuto, F. (2020) · Periodontology 2000 · doi:10.1111/prd.12299 · Cited by 155
Pathophysiology and clinical significance of atherosclerotic plaque rupture
Gutstein, D. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00322-8 · Cited by 151
Danesh, J. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70270-x · Cited by 146
Infections and endothelial cells
Keller, T. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00354-7 · Cited by 116
Metadata
- Authors
- Gupta, S., Leatham, E. W., Carrington, D., Mendall, M. A., Kaski, J. C., & Camm, A. J.
- Venue
- Circulation
- Published
- 1997-07-15
- Volume
- 96
- Issue
- 2
- Pages
- 404-407
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2061940963
- Cited by
- 706
- References
- 18
- FWCI
- 39.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.